DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Misonidazole is an investigational drug.
There have been 13 clinical trials for Misonidazole. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2012.
The most common disease conditions in clinical trials are Glioblastoma, Lung Neoplasms, and Carcinoma, Squamous Cell. The leading clinical trial sponsors are National Cancer Institute (NCI), Proacta, Incorporated, and University of Arkansas.
Recent Clinical Trials for Misonidazole
|Feasibility of FMISO in Brain Tumors||National Cancer Institute (NCI)||Phase 2|
|Feasibility of FMISO in Brain Tumors||OHSU Knight Cancer Institute||Phase 2|
|Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment||Abramson Cancer Center of the University of Pennsylvania||Phase 1|